Your browser doesn't support javascript.
loading
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF.
Docherty, Kieran F; Jhund, Pardeep S; Anand, Inder; Bengtsson, Olof; Böhm, Michael; de Boer, Rudolf A; DeMets, David L; Desai, Akshay S; Drozdz, Jaroslaw; Howlett, Jonathan; Inzucchi, Silvio E; Johanson, Per; Katova, Tzvetana; Køber, Lars; Kosiborod, Mikhail N; Langkilde, Anna Maria; Lindholm, Daniel; Martinez, Felipe A; Merkely, Béla; Nicolau, Jose C; O'Meara, Eileen; Ponikowski, Piotr; Sabatine, Marc S; Sjöstrand, Mikaela; Solomon, Scott D; Tereshchenko, Sergey; Verma, Subodh; McMurray, John J V.
Afiliação
  • Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, UK (K.F.D., P.S.J., J.J.V.M.).
  • Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, UK (K.F.D., P.S.J., J.J.V.M.).
  • Anand I; Department of Cardiology, University of Minnesota, Minneapolis (I.A.).
  • Bengtsson O; Late Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., P.J., A.M.L., D.L., M.S.).
  • Böhm M; Department of Medicine, Saarland University Hospital, Homburg/Saar, Germany (M.B.).
  • de Boer RA; Department of Cardiology, University Medical Center Groningen, University of Groningen, The Netherlands (R.A.d.B.).
  • DeMets DL; Department of Biostatistics & Medical Informatics, University of Wisconsin, Madison (D.L.D.).
  • Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (A.S.D., S.D.S.).
  • Drozdz J; Department of Cardiology, Medical University of Lodz, Poland (J.D.).
  • Howlett J; University of Calgary, Cumming School of Medicine and Libin Cardiovascular Institute, Alberta, Canada (J.H.).
  • Inzucchi SE; Section of Endocrinology, Yale University School of Medicine, New Haven, CT (S.E.I.).
  • Johanson P; Late Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., P.J., A.M.L., D.L., M.S.).
  • Katova T; Clinic of Cardiology, National Cardiology Hospital, Sofia, Bulgaria (T.K.).
  • Køber L; Department of Cardiology Copenhagen University Hospital, Denmark (L.K.).
  • Kosiborod MN; Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.N.K.).
  • Langkilde AM; The George Institute for Global Health and University of New South Wales, Sydney, Australia (M.N.K.).
  • Lindholm D; Late Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., P.J., A.M.L., D.L., M.S.).
  • Martinez FA; Late Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., P.J., A.M.L., D.L., M.S.).
  • Merkely B; Universidad Nacional de Córdoba, Argentina (F.A.M.).
  • Nicolau JC; Heart and Vascular Center, Semmelweis University, Budapest, Hungary (B.M.).
  • O'Meara E; Instituto do Coracao (InCor), Hospital das Clínicas Faculdade de Medicina, Universidade de São Paulo, Brazil (J.C.N.).
  • Ponikowski P; Department of Cardiology, Montreal Heart Institute, Ontario, Canada (E.O'M.).
  • Sabatine MS; Center for Heart Diseases, University Hospital, Wroclaw Medical University, Poland (P.P.).
  • Sjöstrand M; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.S.S.).
  • Solomon SD; Late Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., P.J., A.M.L., D.L., M.S.).
  • Tereshchenko S; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (A.S.D., S.D.S.).
  • Verma S; Department of Myocardial Disease and Heart Failure, National Medical Research Center of Cardiology, Moscow, Russia (S.T.).
  • McMurray JJV; Division of Cardiac Surgery, St. Michael's Hospital, University of Toronto, Ontario, Canada (S.V.).
Circulation ; 142(17): 1623-1632, 2020 10 27.
Article em En | MEDLINE | ID: mdl-32883108
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Volume Sistólico / Compostos Benzidrílicos / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Circulation Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Volume Sistólico / Compostos Benzidrílicos / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Circulation Ano de publicação: 2020 Tipo de documento: Article